International Clinical Trial: A Phase II Clinical Study Based on Endoscopic Laser Ablation Combined with Enfortumab Vedotin and Toripalimab for the Treatment of Localized High-Risk Upper Tract Urothelial Carcinoma

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121637) titled 'A Phase II Clinical Study Based on Endoscopic Laser Ablation Combined with Enfortumab Vedotin and Toripalimab for the Treatment of Localized High-Risk Upper Tract Urothelial Carcinoma' on April 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital of Sichuan University

Condition: Upper Tract Urothelial Carcinoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-04-01

Target Sample Size: experimental group:55;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=302022

Published by HT D...